Protective effect of cultured bear bile powder against dimethylnitrosamine-induced hepatic fibrosis in rats

https://doi.org/10.1016/j.biopha.2019.108701Get rights and content
Under a Creative Commons license
open access

Highlights

  • Cultured bear bile powder (CBBP) has potential to attenuate liver fibrosis.

  • CBBP improved hepatic necrosis/inflammation & reversed serum metabolite changes.

  • CBBP affected metabolic pathways related to biosynthesis of unsaturated fatty acids, fatty acid biosynthesis and metabolism.

  • CBBP treatment stimulated liver expression of PPARα and PPARγ.

Abstract

Natural bear bile has been used for liver disease in East Asia for thousands of years. However, its use has restrictions. In the current study, the therapeutic effects and potential mechanisms of cultured bear bile powder (CBBP) against hepatic fibrosis were evaluated in a dimethylnitrosamine (DMN)-induced rat model. CBBP treatment significantly improved DMN-induced hepatic necrosis and inflammatory infiltration. Additionally, CBBP remarkably alleviated the increased hepatic collagen content and expression of alpha-smooth muscle actin. Serum metabolomics revealed that 14 serum metabolites, including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) were decreased in DMN-treated rats, which was reversed by CBBP. Pathway analyses revealed that the main metabolic pathways affected by CBBP were related to fatty acid biosynthesis and metabolism, and biosynthesis of unsaturated fatty acids. EPA and DHA are ligands of peroxisome proliferator activated receptors (PPARs). CBBP treatment significantly stimulated liver mRNA and protein expression of PPARα and PPARγ. CBBP also markedly increased liver expression of PPARα target genes, which are involved in fatty acid β-oxidation, and down-regulated IL-6, a downstream inflammatory gene of PPARγ. In conclusion, CBBP has the potential to attenuate liver fibrosis and its mechanism involves the promotion of the liver expression of PPARα and PPARγ. Our results may help in the development of a novel substitute for bear bile and therapeutic strategies for fibrotic liver diseases.

Keywords

Liver fibrosis
Cultured bear bile powder
Metabolomics
Dimethylnitrosamine

Cited by (0)

1

These authors contributed equally to this work.